Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm

Author:

Boyle Frances12,Beith Jane23,Burslem Katie4,de Boer Richard5,Hui Rina26,Lim Elgene78,McCarthy Nicole910,Redfern Andrew11,Woodward Natasha1012

Affiliation:

1. Mater Hospital; North Sydney NSW 2060 Australia

2. University of Sydney; Sydney NSW 2006 Australia

3. Chris O'Brien Lifehouse; Camperdown NSW 2050 Australia

4. WriteSource Medical Pty Ltd; Lane Cove NSW 1595 Australia

5. Peter MacCallum Cancer Centre; Melbourne VIC 3000 Australia

6. Westmead Hospital; Westmead NSW 2145 Australia

7. St.Vincent's Clinical School; University of New South Wales; Darlinghurst NSW 2010 Australia

8. Garvan Institute of Medical Research; Darlinghurst NSW 2010 Australia

9. ICON Cancer Care Wesley; Auchenflower QLD 4066 Australia

10. University of Queensland; St Lucia QLD 4072 Australia

11. Fiona Stanley Hospital; Perth WA 6150 Australia

12. Mater Misericordiae Ltd and Mater Research Institute Raymond Terrace; South Brisbane QLD 4101 Australia

Funder

Novartis Pharmaceuticals Australia

Publisher

Wiley

Subject

Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3